ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

1.65
0.025 (1.54%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 1.54% 1.65 1.60 1.70 1.70 1.625 1.63 27,752,936 15:13:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.74 8.96M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.63p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £8.96 million. Genedrive has a price to earnings ratio (PE ratio) of -1.74.

Genedrive Share Discussion Threads

Showing 5101 to 5122 of 27075 messages
Chat Pages: Latest  207  206  205  204  203  202  201  200  199  198  197  196  Older
DateSubjectAuthorDiscuss
28/1/2021
08:31
This is going back to triple digits. Only a matter of time.
genierub
28/1/2021
08:30
Bgf are selling large they will kill this silly rise
justtrying1
28/1/2021
08:27
If the pros have deployed their monkey (justtrying1), you know we're onto something good.

She's the best contra-indicator on ADVFN.

hodhasharon
28/1/2021
08:26
USA USA USA!!!!

The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.

"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."

The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

billthebank
28/1/2021
08:24
Need that gap on the chart to close guys.
tidy 2
28/1/2021
08:21
This willNever ever ever be like ncytNor will it goTo 300pEver again
justtrying1
28/1/2021
08:21
Dropping like a stone
justtrying1
28/1/2021
08:21
HoldFor whatHundreds have bee. Waiting for this to dumpNow rhey are only lemmings buying now
justtrying1
28/1/2021
08:18
Don't sell your share cheap. Hold Hold Hold as these will be worth above 500p by June with all the other potential news flow imo
seball
28/1/2021
08:17
Sell off now
justtrying1
28/1/2021
08:17
still cant buy nt to buy
bunz3
28/1/2021
08:15
well they are getting them, all the braggers are selling theirs!
abbynat
28/1/2021
08:14
Omg whats happened?? Orders?Yay bought at 1.20 so great to see this finally
yasyas1
28/1/2021
08:14
with share supply looking to be low will a £1 be next
bunz3
28/1/2021
08:13
nt to buy

they look to be running low with shares

bunz3
28/1/2021
08:12
My estimates....100p, back to 75p prior to US open. 250p, pullback, 300p + by close tomorrow.
hodhasharon
28/1/2021
08:12
Now the dump
justtrying1
28/1/2021
08:10
can any one buy ,

that 10,000 share buyer timed buying nice ,this looking like might be ready for much higher share prices

bunz3
28/1/2021
08:08
Talks of commercial side of things starting in Feb....still behind the curve, but encouraging
qs99
28/1/2021
08:08
David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.

"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."

seball
28/1/2021
08:07
Beckman Coulter have a 2.8 billion dollar market cap. They realise how good Genedrive product is.
seball
28/1/2021
08:02
What did novacyt peak at...
p winky
Chat Pages: Latest  207  206  205  204  203  202  201  200  199  198  197  196  Older